[go: up one dir, main page]

WO2015132367A1 - Appareil de traitement de l'air - Google Patents

Appareil de traitement de l'air Download PDF

Info

Publication number
WO2015132367A1
WO2015132367A1 PCT/EP2015/054690 EP2015054690W WO2015132367A1 WO 2015132367 A1 WO2015132367 A1 WO 2015132367A1 EP 2015054690 W EP2015054690 W EP 2015054690W WO 2015132367 A1 WO2015132367 A1 WO 2015132367A1
Authority
WO
WIPO (PCT)
Prior art keywords
air
treatment apparatus
air flow
air treatment
conduit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2015/054690
Other languages
English (en)
Inventor
Graham Deane
Kevin Maughan
Felipe Soberon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novaerus Patents Ltd
Original Assignee
Novaerus Patents Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novaerus Patents Ltd filed Critical Novaerus Patents Ltd
Publication of WO2015132367A1 publication Critical patent/WO2015132367A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05H—PLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
    • H05H1/00—Generating plasma; Handling plasma
    • H05H1/24—Generating plasma
    • H05H1/2406—Generating plasma using dielectric barrier discharges, i.e. with a dielectric interposed between the electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/16—Disinfection, sterilisation or deodorisation of air using physical phenomena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/16—Disinfection, sterilisation or deodorisation of air using physical phenomena
    • A61L9/22—Ionisation
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F24—HEATING; RANGES; VENTILATING
    • F24F—AIR-CONDITIONING; AIR-HUMIDIFICATION; VENTILATION; USE OF AIR CURRENTS FOR SCREENING
    • F24F3/00—Air-conditioning systems in which conditioned primary air is supplied from one or more central stations to distributing units in the rooms or spaces where it may receive secondary treatment; Apparatus specially designed for such systems
    • F24F3/12—Air-conditioning systems in which conditioned primary air is supplied from one or more central stations to distributing units in the rooms or spaces where it may receive secondary treatment; Apparatus specially designed for such systems characterised by the treatment of the air otherwise than by heating and cooling
    • F24F3/16—Air-conditioning systems in which conditioned primary air is supplied from one or more central stations to distributing units in the rooms or spaces where it may receive secondary treatment; Apparatus specially designed for such systems characterised by the treatment of the air otherwise than by heating and cooling by purification, e.g. by filtering; by sterilisation; by ozonisation
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05H—PLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
    • H05H1/00—Generating plasma; Handling plasma
    • H05H1/24—Generating plasma
    • H05H1/2406—Generating plasma using dielectric barrier discharges, i.e. with a dielectric interposed between the electrodes
    • H05H1/2431—Generating plasma using dielectric barrier discharges, i.e. with a dielectric interposed between the electrodes using cylindrical electrodes, e.g. rotary drums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2209/00—Aspects relating to disinfection, sterilisation or deodorisation of air
    • A61L2209/10—Apparatus features
    • A61L2209/11—Apparatus for controlling air treatment
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05H—PLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
    • H05H2245/00—Applications of plasma devices
    • H05H2245/10—Treatment of gases
    • H05H2245/15—Ambient air; Ozonisers

Definitions

  • the present application relates to an air treatment apparatus and in particular to an apparatus and method for the removal of airborne pollutants or impurities such as micro-organisms, smoke particles or odours from air by means of exposure to anti-pathogenic agents generated by an atmospheric plasma discharge.
  • the plasma discharge and the agents generated by the same are responsible for the killing of bacteria, viruses and other pathogens in the air.
  • the plasma discharge and the generated agents are also responsible for the dissociation of other pollutants present in the air.
  • HEPA filters High Efficiency Particulate Air (HEPA) filters (defined as removing 99.97% of particles of 0.3 micron size) and electrostatic HAF (High Airflow, electret) filters capable of similar performance at higher airflows are commonly used.
  • HEPA filters High Efficiency Particulate Air (HEPA) filters
  • electrostatic HAF High Airflow, electret filters
  • filters suffer from the disadvantages that trapped (and potentially infective) material remains on the filters, necessitating frequent changes of filter and remaining a hazard until the filters are replaced. This is a particular problem where the air being filtered is humid. In addition, such filters are incapable of removing small viral particles.
  • the Health and Safety Executive recommendation (EH38) is that the exposure limit to ozone should be 0.1 ppm (0.2 mg m ⁇ -3> ) as an 8- hour time-weighted average concentration, with a short-term exposure limit of 0.3 ppm (0.6 mg m ⁇ -3> ) as a 15-minute time-weighted average concentration.
  • Figure 1 is a plan view showing in schematic form components of an air treatment apparatus provided in accordance with the present teaching.
  • Figure 2 is a schematic representation of an air flow through an apparatus such as shown in Figure 1 .
  • the current teachings relate to using a plasma discharge field to effectively sterilise air of micro-organisms or pathogens or remove airborne contaminants and particles in such a way that the air is only transiently exposed to high concentrations of anti-pathogenic agents produced by the plasma discharge and is returned to the environment with the level of anti-pathogenic agents reduced to acceptable levels for safe exposure of those living or working in the immediate environment.
  • An air treatment apparatus 100 comprises a housing 1 1 1 within which a conduit 101 provides a fluid communication path between an inlet 102 and an outlet 103.
  • the form and dimensions of these components may vary dependent on the application environment or volume of air intended to be treated. It will be appreciated that air enters the housing through the inlet 102, proceeds in the direction of the arrows and exits at outlet 103.
  • the housing or casing 1 1 1 is dimensioned to support and retain operating elements of the apparatus such as a power supply 1 10 and other elements as will be described hereinafter. Controls 108 for operation of the apparatus can be mounted outside the housing 1 1 1 for ease of user accessibility.
  • the housing 1 1 1 is generally in the form of a box, cabinet, casing or the like.
  • the housing 1 1 1 may be formed of any convenient material.
  • the type and specifics of the controls 108 are not important are used for turning the apparatus on and off, setting a timer for the apparatus etc. User inputs made at the controls can directly affect the generation of a plasma discharge and anti-pathogenic agents in the apparatus 100.
  • the acceleration of an air flow through the housing is effected by provision of at least one air flow impeller 104, most conveniently an electrically-driven fan arranged to efficiently draw air from the inlet 102 to the outlet 103 through the conduit 101 .
  • the impeller 104 is capable of running at a relatively wide range of flow rates.
  • the conduit 101 preferably follows a non-rectilinear path as this requires less turbulence to be generated in the air flow by the impeller 104 when compared to a linear conduit.
  • the apparatus also includes at least one plasma discharge unit or generator 109 mounted inside the conduit 101 .
  • the discharge unit 109 is desirably provided proximal to the air inlet 102 such that air assisted into the conduit by the impeller 104 will pass over the discharge unit.
  • the region between the air impeller and the generator defines an upstream stage 105 of the conduit 101 .
  • the region between the discharge unit 109 and the outlet 103 defines a downstream stage of the conduit.
  • the discharge unit 109 is arranged for generating plasma with an inactivating zone proximal to the discharge unit.
  • This inactivating zone will extend both into the upstream and downstream stages of the conduit but operably the direction of the induced air flow effected by the impeller causes the inactivating zone to extend further into the downstream stage that into the upstream stage.
  • the discharge unit 109 is desirably orientated to extend transverse to the direction of the air flow.
  • the unit 109 provides a baffle such that air introduced into the fluid path will encounter an obstacle in the form of the unit 109 that serves to obstruct the flow of air in the conduit 101 .
  • the positioning and shape of the discharge unit 109 is important as will be explained in more detail with reference to figure 2. Specifically, the position and shape of the discharge unit 109 ensures that a substantial portion of air flowing through is subjected to anti- pathogenic agents produced by the plasma field of the discharge unit 109.
  • discharge unit 109 is shown in the conduit 101 in figure 1 , it will be appreciated that multiple discharge units 109 can be included therein in any suitable configuration.
  • an array of discharge units may be distributed across the airflow path in the upstream stage 105.
  • two or more discharge units may be provided in series such that air passing through the fluid path will sequentially encounter each of the individual generators and experience successive exposure to reactive species generated by the generators.
  • the restricted anti-pathogenic agent concentration in the inactivating zone, created by the discharge unit 109, is sufficient to effectively inactivate airborne pollutant material entrained in the air flow. Furthermore the concentration of anti-pathogenic agents decays sufficiently outside the inactivating zone so that the concentration of anti-pathogenic agents in the cleaned air expelled from the outlet 103 of the apparatus 100 is at a physiologically acceptable level.
  • the inner surface of the conduit 101 may optionally be coated with a conductive material.
  • a midstream stage 106 and a downstream stage 107 which is coupled to the midstream stage 106 may also being be coated with a conductive material from inside. It can be understood that the anti-pathogenic agents are transported from the upstream stage 105 passed the inactivating zone to the outlet 103.
  • the combined length of the midstream and downstream stages stage is greater than the length of the upstream stage and is selected so as to exceed the path length required for neutralisation of the produced anti- pathogenic agent. In this way it is possible to ensure that the air exiting the device at outlet 103 contains anti-pathogenic agents at a harmless level.
  • anti-pathogenic agents produced by plasma generated spontaneously by the discharge unit 109 break down.
  • the half-life in air is dependent on a variety of factors including temperature and concentration but is generally at least several minutes or hours. However, this half-life is generally significantly shortened by humidity and by the presence of oxidizable substrates, solid surfaces and specific catalysts.
  • the three stages of the conduit 101 can be of uniform width and shape or formed from a single unitary body but most likely formed individually, possibly of different width and shape, and joined together.
  • the configuration of the stages of the conduit 101 can be chosen as appropriate by those skilled in the art. The most important consideration is the length of the conduit 101 (in particular mid stage 106), which must be of sufficient length to restrict or reduce the anti-pathogenic agents level in the air to a safe level by the time the air exits the apparatus at outlet 103.
  • the conduit is comprised of metal, for example steel or aluminium, or a plastics material (or GRP) impregnated and/or coated with metallic material, suitable to suppress radio frequency (RF) interference resulting from the dielectric barrier discharge and is suitably earthed.
  • RF radio frequency
  • the RF disturbance may interrupt the effective performance of other electrical components in the circuit.
  • the conduit 101 is sealed from other components and wiring of the apparatus such as the transformer 107 (the operation of which will be explained below) to ensure the forced airflow is directed through said upstream 105, midstream 106, and downstream 107 stages of the conduit 101 without any interference by such components.
  • air entering the apparatus at inlet 102 is only obstructed by the discharge unit(s) 109 in the conduit prior to exiting at the outlet 103.
  • deflectors 1 10 are preferably provided at the corners of the conduit 101 to minimise interference with the airflow as well as to ensure that air is not trapped in the corners. These deflectors also reduce the gas pressure at the corners. It will be appreciated that deflectors 1 10 are not required if the conduit is suitable shaped i.e., rounded corners. Even in such a curvaceous path, the air still experiences a tortuous path through the housing.
  • conduit such that the air in the conduit 101 does not interact with other components of the apparatus 100 (other than the discharge unit 109) ensures that these other components are not damaged or contaminated by exposure to plasma or anti-pathogenic agents in the air.
  • this unit 109 is formed and arranged so that an inactivating zone is contained within the conduit 101 i.e. does not extend outside of the confines of the conduit 101 .
  • the inactivating zone is the combination of all upstream 105, mid 106, and downstream 107 stages because anti-pathogenic agents tend to disperse in the whole volume and cause deactivation of micro-organisms therein.
  • low power coronal discharge plasma units 109 also have significant safety benefits in the case of any possible apparatus malfunctions, maintenance operations etc.
  • Power to provide a suitable plasma generating dielectric barrier discharge i.e., to power the discharge unit 109 is suitably provided by transformer 1 10 providing a low power high-voltage alternating current.
  • the transformer 107 is setup for a duty cycle of 5 minutes ON and 5 minutes OFF. This means that the discharge unit 109 only generates or discharges plasma in 5 minute blocks. This duty cycle of 5 minutes ON/OFF is chosen in order to control the excess production of plasma and anti- pathogenic agents by the discharge unit 109 in the apparatus 100. It will be appreciated that any duty cycle can be chosen as appropriate by a user via the controls 108. The rate of airflow through the conduit can also be chosen by a user via the controls 108.
  • the voltage and current parameters of the discharge unit 109 required to achieve a dielectric barrier discharge will depend principally on the nature of the dielectric used, as further discussed herein below. In general operating voltages below 1 kV are not practical, and preferably there is used an operating voltage in the range from 1 to 6 kV, most desirably from 3 to 5 kV, for example about 4 kV. It will be appreciated that the current required to maintain the dielectric barrier discharge is significantly less than that required to initiate it.
  • the current (and hence power) of plasma generator units is normally expressed in terms of the starting current. There should be used a (starting) current in the range from 1 to 10 mA, preferably at least 3 mA.
  • the power of the unit will of course depend on the voltage and current combination. Restriction of the power of the unit helps to ensure that the inactivation field is contained within the conduit 101 . In this connection it will be appreciated that a somewhat higher power unit might, in principle, be used with a larger conduit 101 .
  • the power should generally be not more than 50 watts, and is preferably at least 4 watts. Typically the power is in the range from 10 to 40 watts. These power levels have in particular been found to be convenient with an apparatus unit having a conduit volume of the order of 0.02 to 1 .0 m3.
  • the transformer 107 is provided with an anti-surge and/or anti-spike device(s), in order to minimize transient excursions of the output voltage above the normal level which could result in temporary extension of the inactivation zone outside of the conduit 101 and/or generation of excessively high anti-pathogenic agent levels.
  • the transformer 1 10 is located outside of the conduit 101 to minimize the risk of exposure to plasma/anti-pathogenic agents and possible breakdown in the course of use of the apparatus 100. As previously mentioned, this also ensures that the transformer does not interfere with the flow of air in the conduit 101 .
  • an AC supply is also provided in the apparatus 100.
  • this is co-located with the transformer 1 10 such that it does not obstruct airflow in the conduit 101 .
  • a wide range of frequencies may be used in the AC supply to the low power dielectric barrier discharge device, and indeed somewhat higher frequencies may safely be used than is possible with conventional high power plasma generators.
  • an AC supply with a frequency in the range from 50 to 1000 Hz may be used.
  • FIG 2 shows the operation of the plasma discharge unit 109 within conduit 101 .
  • discharge unit 109 is showing obstructing the airflow 201 passing from the upstream stage 105 of the conduit 101 .
  • the conduit should not be smaller than a volume required to contain the inactivation zone of the plasma discharge generator(s) 109, and not so large that substantially the whole of the airflow 201 does not pass through said inactivating zone 202 in the course of its transit through the conduit 101 .
  • the discharge unit 109 is placed such that substantially all of the airflow 201 passes through the inactivating zone 203.
  • the shape of the discharge unit is important in directing the airflow 201 around the discharge unit 109 through highly inactivating zones 203 and into inactivating zone 202, which is less inactivating than zone 203.
  • the inactivating zone 202 is a volume surrounding the discharge unit 109 containing an elevated concentration of anti-pathogenic agents, sufficient to substantially inactivate airborne pollutants or pathogens.
  • the inactivating zone 202 is situated on the outer surface of the discharge unit 109 and in a downstream direction.
  • the total inactivating zone (combination of inactivating zones 202 and 203) is the combination of all upstream, mid, and downstream stages as anti-pathogenic agents tend to disperse in whole volume and cause deactivation of microorganisms.
  • airflow 201 is passed over and under the discharge unit 109 and not passed through it i.e., there are no air gaps within the discharge unit that allow air to enter or that could potentially hold a build-up in anti-pathogenic agents.
  • low power discharge units 109 are known in the art but these are conventionally associated with ozone generators.
  • a discharge unit is provided that is is desirably used with a solid dielectric 205 to provide a dielectric barrier discharge which the present inventors have found provides a more consistent and reliable plasma generation performance.
  • Various geometries are also possible. However, for the present application, a generally tubular geometry, with a tubular dielectric with generally tubular electrodes 204 on the inner and outer faces thereof is preferred. This tubular shape works to direct the airflow 201 around the discharge unit 109 as shown in figure 2. It will be appreciated that plasma will be generated at both electrodes 204.
  • a generally mesh form electrode 204 providing a coil, in order to maximize the areas of dielectric surface at which plasma is generated.
  • substantially “closed” meshes are less desirable as these reduce the exposed dielectric surface.
  • excessively “open” meshes are generally less efficient in the amount of plasma generated for a give size of unit.
  • the electrodes 204 are perfectly coaxial cylindrical mesh where the dielectric 205 is sandwiched between them.
  • the low power discharge unit comprises concentric tubular metal gauze electrodes 204 separated by a dielectric.
  • the low power discharge plasma unit 109 comprises tubular stainless steel gauze electrodes 204.
  • gauze electrodes 204 are particularly convenient due to inter alia its resistance to corrosion and to oxidative and other damage from the plasma discharge.
  • the purpose of gauze electrodes 204 is to maximize the surface available for the dielectric barrier discharge and hence generation of plasma.
  • other factors such as the effects on the electromagnetic field generated, particularly hysteresis effects relating to the generation and collapse of the field during the 50 Hz cycle of the alternating current, also influence the choice of gauze and the fineness of the mesh.
  • the gauze on the outer electrode 204 is coarser than that of the inner electrode 204 as this favours the production of plasma on the outer, rather than inner, electrode 204.
  • the mesh count of the inner electrode 204 is from 50 to 30 * 45 to 25 (per inch or 25.4 mm) and that of the outer electrode 204 is 35 to 20 * 40 to 20.
  • the mesh count of the inner electrode 204 is 40 * 34 (per inch or 25.4 mm) using a 38 swg wire (0.15 mm diameter) and that of the outer electrode is 24 * 28 using a 30 swg wire (0.3 mm diameter).
  • the mass of the electrodes 204 be substantially balanced, i.e. to differ by not more than 20%, preferably not more than 10%. This is especially significant in the case of the aforementioned tubular configuration discharge unit 109.
  • each of the mesh electrodes 204 should have an area in the range from 25 to 100 cm2, preferably from 40 to 90 cm2.
  • a coil provided in accordance with the present teaching is one having a length of 5.5cm or 13cm and having a diameter of 2.9 cm diameter. Such coils will have exemplary areas of 50 and 1 18 cm2 respectively.
  • the power consumed by the plasma coils is in the range 10 to 20 W resulting in power density of 0.2 to 0.4 W/cm2 and 0.08 to 0.16 W/cm2 for each coil.
  • a plasma generator comprising a coil per the present teaching will operate with power density values less than 1 W/cm 2 and typically in the range from 0.1 to 0.5 W/cm2.
  • Plasma generation occurs during the negative half cycle of the alternating current, at each electrode 204 in turn.
  • the airflow 201 removes anti-pathogenic agents from the discharge area 203 as it is formed. This leads to a net production of anti-pathogenic agents.
  • the electrochemistry of such methods of plasma production is known in the art.
  • the apparatus of figure 1 can be mounted for operation on a wall.
  • any supporting structure that is sufficient to hold the apparatus 301 could be used instead of the wall.
  • An inlet and the outlet should preferably be both disposed on the underside of the apparatus and are also spaced apart for maximum efficiency. This ensures that air exiting from outlet is not simply returned to the apparatus via the inlet.
  • the present design is free from any filters i.e., it does not uses air filters such as HEPA filters for air sterilization.
  • air filters such as HEPA filters for air sterilization.
  • the positioning of the inlet and outlet at the underside of the device minimising the particle collection at the outlet.
  • the restricted concentration of anti-pathogenic agents produced at the plasma discharge unit can be controlled by tuning or adjusting discharge power, dielectric barrier width, electrode configuration, airflow, and applied frequency.
  • Typical electrical operation parameters of the apparatus are in the range of some kV ignition voltage from line frequency to several MHz and power consumption of some W per dm2 electrode area.
  • the gas temperature reaches up to 150 C.
  • Various forms of impeller may be used. Conveniently there is used an electric fan running at a speed of the order of 2000 to 4000 rpm. A range of different flow rates may conveniently be obtained for a given fan speed by simply changing the fan blade angle.
  • the apparatus can also be used in an upright position, on a secure level surface such that air enters and exits the apparatus horizontally.
  • the apparatus is designed to provide substantially complete inactivation in a single pass-at least at typical pollutant loading levels in enclosed working, residential, transportation, recreational and like environments, whilst restricting anti-pathogenic agent emissions to physiologically acceptable levels.
  • Naturally higher than average pollutant loadings and/or more resistant pollutants may require somewhat lower maximum air flow rates and/or multiple passes through the apparatus, than are required for other cases.
  • the inactivating effect of the apparatus of the present teachings may be used for inactivating a wide range of pollutants, including inter alia microbiological pollutants such as airborne bacteria, viruses and fungal spores, smoke, and various volatile organic compounds, in a wide range of situations so as to improve the quality of the air.
  • microbiological pollutants such as airborne bacteria, viruses and fungal spores, smoke, and various volatile organic compounds
  • Exemplary testing of an apparatus provided in accordance with the present teaching showed efficacy in killing both bacteria and virus.
  • Table 1 shows exemplary data for bacteria testing whereas Table 2 shows similar results for viral testing.
  • the apparatus may be installed in ducting or pipework carrying a flow of air, such as may for example be used in an air-conditioning system.
  • the amount of treatment required will depend on the nature of the pollutant/pathogen, and possibly also the burden or loading thereof in the air. Whilst there may in principle be used multiple passes to progressively reduce the pollutant/pathogen loading, it is a particular advantage of the invention that the relatively high anti-pathogenic agent concentrations which can be achieved with apparatus of the invention within the contained inactivation zone, can usually provide substantially complete inactivation within a single pass, thereby minimizing the number of air changes required.

Landscapes

  • Engineering & Computer Science (AREA)
  • Plasma & Fusion (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Combustion & Propulsion (AREA)
  • Chemical & Material Sciences (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)

Abstract

L'invention concerne un appareil de traitement de l'air comprenant : un conduit définissant un trajet d'écoulement d'air non rectiligne entre une entrée et une sortie ; au moins une roue à flux d'air formée et agencée de façon à induire un flux d'air à travers ledit trajet de flux d'air ; et un générateur de plasma placé dans le trajet de flux d'air et orienté transversalement par rapport au flux d'air induit, le générateur étant configuré pour produire de façon opérationnelle un plasma avec une concentration d'agents anti-pathogènes limitée à la circonférence autour d'un axe longitudinal du générateur de plasma pour définir une zone d'inactivation dudit trajet de flux d'air à l'intérieur de laquelle des particules ou des constituants de l'air à l'intérieur du flux d'air induit vont être exposés aux agents anti-pathogènes.
PCT/EP2015/054690 2014-03-05 2015-03-05 Appareil de traitement de l'air Ceased WO2015132367A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201461948256P 2014-03-05 2014-03-05
US61/948,256 2014-03-05
GB1404186.7 2014-03-10
GB1404186.7A GB2524009A (en) 2014-03-10 2014-03-10 Air treatment apparatus

Publications (1)

Publication Number Publication Date
WO2015132367A1 true WO2015132367A1 (fr) 2015-09-11

Family

ID=50554799

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2015/054690 Ceased WO2015132367A1 (fr) 2014-03-05 2015-03-05 Appareil de traitement de l'air

Country Status (2)

Country Link
GB (1) GB2524009A (fr)
WO (1) WO2015132367A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2686484C1 (ru) * 2018-02-19 2019-04-29 Федеральное государственное бюджетное образовательное учреждение высшего образования "Красноярский государственный аграрный университет" Устройство для обеззараживания воздуха
CN112807472A (zh) * 2021-01-14 2021-05-18 山东派力迪环境科技有限公司 医院中心吸引系统排气在线实时消毒灭菌除味的处理方法
US11027038B1 (en) 2020-05-22 2021-06-08 Delta T, Llc Fan for improving air quality
KR20210083223A (ko) * 2020-02-07 2021-07-06 배준형 고밀도 융합 플라즈마 살균 및 탈취기
EP4005667A1 (fr) * 2020-11-27 2022-06-01 Plasma Innova S.A. Appareillage de purification d'air au plasma non-thermique
US11400177B2 (en) 2020-05-18 2022-08-02 Wangs Alliance Corporation Germicidal lighting

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11633511B2 (en) 2018-07-13 2023-04-25 The Regents Of The University Of Michigan Production of immune-response-stimulating aerosols by non-thermal plasma treatment of airborne pathogens
EP4145051B1 (fr) 2020-07-22 2024-07-03 Fermion Instruments (Shanghai) Co., Ltd. Générateur de plasma et système de traitement au plasma

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060182672A1 (en) * 2003-07-18 2006-08-17 Hallam David R Air cleaning device
US20070253860A1 (en) * 2004-10-18 2007-11-01 Werner Schroder Process and device for sterilising ambient air
US20100024652A1 (en) * 2008-08-01 2010-02-04 3M Innovative Properties Company Apparatus, system, and method for enhancing air purification efficiency
WO2011123512A1 (fr) * 2010-03-31 2011-10-06 Drexel University Système de plasma pour stérilisation de l'air
WO2013076459A1 (fr) * 2011-11-25 2013-05-30 Tri-Air Developments Limited Cellule de plasma non thermique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3709449B1 (ja) * 2003-08-29 2005-10-26 ダイキン工業株式会社 ガス処理装置
JP4095620B2 (ja) * 2004-05-07 2008-06-04 キヤノン株式会社 ガス処理装置
CN101502665B (zh) * 2008-10-09 2015-03-18 浙江佩洁尔医疗科技有限公司 风机盘管型等离子体空气消毒净化器
CN201586248U (zh) * 2009-12-31 2010-09-22 周云正 隧道空气消毒净化器
CN201715597U (zh) * 2009-12-31 2011-01-19 周云正 设有等离子体净化的抽油烟机
KR101039069B1 (ko) * 2010-06-28 2011-06-08 낙천 제임스 백 공기 청정 및 살균용 플라즈마 처리기
CN103303099A (zh) * 2013-05-10 2013-09-18 苏州市昆士莱照明科技有限公司 汽车空调

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060182672A1 (en) * 2003-07-18 2006-08-17 Hallam David R Air cleaning device
US20070253860A1 (en) * 2004-10-18 2007-11-01 Werner Schroder Process and device for sterilising ambient air
US20100024652A1 (en) * 2008-08-01 2010-02-04 3M Innovative Properties Company Apparatus, system, and method for enhancing air purification efficiency
WO2011123512A1 (fr) * 2010-03-31 2011-10-06 Drexel University Système de plasma pour stérilisation de l'air
WO2013076459A1 (fr) * 2011-11-25 2013-05-30 Tri-Air Developments Limited Cellule de plasma non thermique

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2686484C1 (ru) * 2018-02-19 2019-04-29 Федеральное государственное бюджетное образовательное учреждение высшего образования "Красноярский государственный аграрный университет" Устройство для обеззараживания воздуха
KR20210083223A (ko) * 2020-02-07 2021-07-06 배준형 고밀도 융합 플라즈마 살균 및 탈취기
KR102315245B1 (ko) 2020-02-07 2021-10-19 배준형 고밀도 융합 플라즈마 살균 및 탈취기
US11400177B2 (en) 2020-05-18 2022-08-02 Wangs Alliance Corporation Germicidal lighting
US11433154B2 (en) 2020-05-18 2022-09-06 Wangs Alliance Corporation Germicidal lighting
US11612670B2 (en) 2020-05-18 2023-03-28 Wangs Alliance Corporation Germicidal lighting
US11696970B2 (en) 2020-05-18 2023-07-11 Wangs Alliance Corporation Germicidal lighting
US12109338B2 (en) 2020-05-18 2024-10-08 Wangs Alliance Corporation Germicidal lighting
US11027038B1 (en) 2020-05-22 2021-06-08 Delta T, Llc Fan for improving air quality
EP4005667A1 (fr) * 2020-11-27 2022-06-01 Plasma Innova S.A. Appareillage de purification d'air au plasma non-thermique
CN112807472A (zh) * 2021-01-14 2021-05-18 山东派力迪环境科技有限公司 医院中心吸引系统排气在线实时消毒灭菌除味的处理方法

Also Published As

Publication number Publication date
GB2524009A (en) 2015-09-16
GB201404186D0 (en) 2014-04-23

Similar Documents

Publication Publication Date Title
WO2015132367A1 (fr) Appareil de traitement de l'air
DK3097750T3 (en) Device for air disinfection and pollution removal
CN107708749B (zh) 用于化学空气污染物的电流体动力增强的破坏和生物剂的空气中灭活的方法
US9370599B2 (en) Coil assembly for plasma generation
KR101305762B1 (ko) 매립형 플라즈마 공기청정기
WO2013065206A1 (fr) Dispositif et procédé de piégeage et d'inactivation de microorganismes et de virus
JP2002065836A (ja) イオン発生装置を備えた空気清浄機並びに空気調和機
KR20050019692A (ko) 공조라인에 설치가능한 공기살균 청정유닛
JP2023513452A (ja) 空気浄化除菌ユニット
JP2002058731A (ja) イオン発生装置を備えた空気清浄機及び空気調和機
CN111617277A (zh) 一种杀菌消毒装置及其杀菌消毒方法
CN206026742U (zh) 一种多级处理空气消毒装置
Liu et al. Reactive air disinfection technologies: principles and applications in bioaerosol removal
Matys et al. Disinfectants and devices for surface and air disinfection in dental offices
CA3182731A1 (fr) Systeme de purification d'air a deux etages pour emplacements fermes
EP4005667A1 (fr) Appareillage de purification d'air au plasma non-thermique
CN205079356U (zh) 对称轴向电离净尘装置
CN212235370U (zh) 一种杀菌消毒装置
US20230338605A1 (en) An air purification system and method
CN202546953U (zh) 风机管盘式等离子体净化消毒器
EP3903910A1 (fr) Dispositif de purification d'air et procédé de purification d'air associé
CN218544617U (zh) 一种风机盘管及中央空调
TWI606860B (zh) 空氣淨化方法
CN218599943U (zh) 一种消毒机
KR20240120872A (ko) 공간살균을 위한 오존 공기청정 살균기

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15710456

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15710456

Country of ref document: EP

Kind code of ref document: A1